- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05970341
Kidney Health: Eat Well, Live Well
"Kidney Health: Eat Well, Live Well": A Program to Reduce Kidney Injury and Early CKD Progression Through Nutrition & Empathetic Support From a Health Partner
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study tests a community-based program aimed at supporting adults with early-stage chronic kidney disease to change their eating habits to reduce the likelihood of kidney injury progression.
The program components were design to reduce barriers to a) eating healthier, kidney-friendly foods through the direct provision of fruits and vegetables, grocery store e-gift cards, kidney-friendly recipes, and food preparation tips; b) learning about kidney disease and the role of healthy eating in slowing its progression through educational materials; and c) social connection through empathetic relational phone calls and SMS texts from a dedicated "Health Partner".
Over a period of 6 months (26 weeks), participants randomized to the intervention arm will receive:
- kidney-friendly produce (fruits and vegetables) delivered at their preferred location
- recipes and tips on food preparation tailored to the produce
- grocery store electronic gift cards
- educational materials on CKD and disease management
- personalized practical and emotional support through a dedicated Health Partner
Researchers will see if participation in the program (intervention) reduces markers of kidney injury (Albumin:Creatinin ratio) and cardiovascular disease risk and improves diet (particularly fruits and vegetables intake) and mental health when compared to usual care (control).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Courtney Mulligan, MA
- Phone Number: 512-522-4349
- Email: Courtney.Mulligan@austin.utexas.edu
Study Contact Backup
- Name: Nicole Clark, MBA
- Phone Number: 210-316-5443
- Email: nicole.clark@austin.utexas.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77026
- Recruiting
- Harris Health System's Outpatient Center
-
Houston, Texas, United States, 77047
- Recruiting
- Harris Health System's Martin Luther King Jr. Health Center
-
Houston, Texas, United States, 77054
- Recruiting
- Harris Health System's Smith Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (18 years of age or older)
- Primary care visit at either one of the three partner clinics from Harris Health [Smith Clinic, Harris Health Outpatient Center (located on the LBJ campus), or Martin Luther King Jr. Health Center (MLK)] and a primary care patient within Harris Health System
- Have had at least 1 visit in the past 18 months with prior history in the clinic (i.e., not first visit)
- Diagnosis of CKD (Stage 2, 3a, and 3b) as defined by estimated Glomerular Filtration Rate (eGFR) ≥ 30 and <90 mL/min/1.73 m2 OR CDK 1 or undiagnosed with urine Albumin Creatinine Ratio ≥ 30 mg/g
- Within the past 12 months, the most current serum K+ ≤ 4.6 mEq/L
- English or Spanish speaking
- Ability to participate in the program at least 6 months
- Ability to clean, prepare, refrigerate/freeze food products that are given to them
- Have access to receive SMS text messages
- Location of preferred produce bag delivery within an available delivery zone
Exclusion Criteria:
- CKD 4, ESRD or on dialysis.
- Taking certain medications chronically (more than twice a week for 90 days) that may interfere with K+ metabolism (such as non-steroidal anti-inflammatory drugs (NSAIDs), as self-reported during enrollment screening
- Taking mineralocorticoid receptor antagonists
- Taking Warfarin
- Diagnosis of any specific kidney conditions (such as polycystic kidney disease, glomerulonephritis, Lupus associated with Nephritis, Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)) that would contraindicate study participation as determined by physician
- Medical history of organ transplant that would contraindicate study participation as determined by physician
- Received immunotherapy for primary or secondary kidney disease within 6 months prior to enrolment
- Diagnostic of heart failure conditions Class IV in the New York Heart Association (NYHA) functional classification
- Had myocardial infarction, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks prior to enrolment
- Had coronary revascularization (PCI, CABG) or valvular repair within 12 weeks prior to enrolment
- On active hospice care as self-reported during enrollment screening
- Diagnosis of active malignancy requiring treatment that would contraindicate study participation as determined by physician
- Has decompensated cirrhosis as determined by physician
- Cognitive impairment that would contraindicate study participation as self-reported during enrollment screening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1: Intervention + usual care
|
At the end of the baseline data collection visit at the clinic, the Research Staff will hand the participant a welcome packet that includes:
Those allocated to the intervention arm will receive a welcome call from the Program Staff to provide further details and expectations about the program (such as delivery details and schedule). Those allocated to the control arm will receive an SMS text that informs them of their arm allocation, what to expect and a phone number to call for questions.
Five (5) e-gift cards to a major local grocery retailer chosen by the participant (from 3 options) at the following frequency:
|
|
Other: Arm 2: Educational materials + usual care
|
At the end of the baseline data collection visit at the clinic, the Research Staff will hand the participant a welcome packet that includes:
Those allocated to the intervention arm will receive a welcome call from the Program Staff to provide further details and expectations about the program (such as delivery details and schedule). Those allocated to the control arm will receive an SMS text that informs them of their arm allocation, what to expect and a phone number to call for questions. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urine albumin:creatinine ratio (UACR)
Time Frame: Baseline, 3 months, 6 months
|
Marker of kidney damage and a useful predictor of cardiovascular (CV) events in adults.
Uses spot urine to estimate 24-hour urine albumin excretion.
UACR > 30 mg/g indicates kidney damage.
|
Baseline, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin A1C
Time Frame: Baseline, 3 months, 6 months
|
Finger stick point-of-care portable device.
Measures the average blood sugar levels over the past 3 months with a result in %.
Higher A1C levels indicate poorer glycemic control and higher risk of diabetes complications.
|
Baseline, 3 months, 6 months
|
|
Blood pressure (systolic/diastolic)
Time Frame: Baseline, 3 months, 6 months
|
Direct measurement with automatic blood pressure cuff.
|
Baseline, 3 months, 6 months
|
|
Anxiety as measured by scores on the Generalized Anxiety Disorder 7-item (GAD-7)
Time Frame: Baseline, 3 months, 6 months
|
Self-administered.
Based on some of the DSM-V criteria for General Anxiety Disorder to identify probable cases of GAD along with measuring anxiety symptom severity.
Responders are asked to rate the frequency of anxiety symptoms in the last 2 weeks on a Likert scale ranging from 0 (not at all) to 3 (nearly every day).
Items are summed to provide a total score (0-21) to inform severity (1-4 minimal symptoms; 5-9 mild symptoms; 10-14 moderate symptoms; 15-21 severe symptoms).
|
Baseline, 3 months, 6 months
|
|
Depressive symptoms as measured by scores on the Patient Health Questionnaire 8-item (PHQ-8)
Time Frame: Baseline, 3 months, 6 months
|
Self-administered.
Based on the nine DSM-V criteria listed under criterion A for Major Depressive Disorder.
Responders are asked to rate the frequency of depression symptoms in the last 2 weeks on a Likert scale ranging from 0 (not at all) to 3 (Nearly every day).
The sum of responses to each item yields a total score that screens for depression and its severity: not depressed (0-2), mild (3-5), moderate (6-8), and severe (9-12).
|
Baseline, 3 months, 6 months
|
|
Loneliness measured by scores on the 3-item UCLA Loneliness Scale
Time Frame: Baseline, 3 months, 6 months
|
Self-administered.
Respondents rate each item as 'Never' , 'Rarely', 'Sometimes' or 'Often'.
Scores range from 3 to 9. Higher numbers imply greater loneliness.
|
Baseline, 3 months, 6 months
|
|
Food intake in the past 30 days as assessed by the Dietary Screener Questionnaire from NHANES 2009-10
Time Frame: Baseline, 3 months, 6 months
|
30-day food frequency questionnaire (screener) that asks for frequency of intake in the past month (per month, per week, or per day) of 28 items such as cereal, red meat, fruits and vegetables. This study includes four food items linked to kidney health (and mostly acid-inducing): eggs, chicken/turkey, fish, and cheese. Questions are asked in the same fashion as the other questions in the tool. |
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of fruits and vegetables consumption
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake from the Dietary Screener Questionnaire, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Reported per fruits and vegetables as cup equivalents/day.
|
Baseline, 3 months, 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social engagement as measured by the Lubben Social Network scale 6-item
Time Frame: Baseline, 6 months
|
Self-administered.
The LSNS-6 is a self-report measure of social engagement with family and friends.
The sum of the all items yields a total score that ranges between 0 and 30, with a higher score indicating more social engagement.
|
Baseline, 6 months
|
|
General health and quality of life as measured by scores on the MOS Short-form 12-item (SF-12)
Time Frame: Baseline, 6 months
|
Self-administered.
Measures physical and mental health status.
Summary scores range from 0-100, with higher scores indicating a better self-reported level of health.
|
Baseline, 6 months
|
|
Estimated Glomerular Filtration Rate (eGFR)
Time Frame: As available 18 months before enrollment in the study and 15 months after study participation ends
|
Obtained from Electronic Health Records.
Any lab result available from 18 months prior to and 15 month post enrollment date will be obtained for study participants.
|
As available 18 months before enrollment in the study and 15 months after study participation ends
|
|
Perception of kidney disease and role of diet as measured by the Brief Illness Perception Questionnaire
Time Frame: Baseline, 6 months
|
Self-administered. Answers are on a 0-10 sliding scale, except for one open-ended ranking question. Increases in item scores represent linear increases in the dimension measured. It contains 9 questions addressing the individual's cognitive perceptions, control over illness, beliefs about the effectiveness of treatment, experience of symptoms and emotional aspects. To better tailor it to the study population, "illness" was replaced by "kidney problem". And one question about perceived impact of food on disease was added to tailor it to the intervention. |
Baseline, 6 months
|
|
Food security status as assessed by the USDA Food Security Survey Module: Six-Item Short Form
Time Frame: Baseline, 6 months
|
Self-administered.
Self-report assessment of access to food in the past 30 days.
The sum of affirmative responses to the six questions in the module yields the household's raw score on the scale.
Scores can range from 0 to 6, with higher scores indicating lower food security.
|
Baseline, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of dairy consumption
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Food group of dairy is reported as cup equivalents/day.
|
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of added sugars
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Reported added sugars as teaspoon equivalents/day.
|
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake and frequency of whole grains
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Reported whole grains as ounce equivalents/day.
|
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of fiber
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Reported fiber as g/day.
|
Baseline, 3 months, 6 months
|
|
Changes in diet quality as estimates of individual mean dietary intake of calcium
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Reported calcium as mg/day.
|
Baseline, 3 months, 6 months
|
|
Changes in diet quality as frequency of red and processed meat consumption
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
And reported red meat and processed meat as frequencies (times per day).
|
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of eggs
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Added for its acid-inducing properties in chronic kidney disease.
Reported as frequencies only (times per day) and amount.
|
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of chicken/turkey
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Added for its acid-inducing properties in chronic kidney disease.
Reported as frequencies only (times per day).
|
Baseline, 3 months, 6 months
|
|
Changes in frequency and intake of fish
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Added for its association with reduced CVD risk.
Reported as frequencies only (times per day).
|
Baseline, 3 months, 6 months
|
|
Changes in type of cheese consumption when reported
Time Frame: Baseline, 3 months, 6 months
|
Changes in diet quality will be measured by obtaining individual mean dietary intake, as well as frequency of food group consumption, as per analytical instructions in the National Cancer Institute, using USDA nutrient database.
Soft vs. hard cheese types added for the acid-inducing properties of hard cheese in chronic kidney disease.
Reported as type associated with dairy consumption.
|
Baseline, 3 months, 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maninder Kahlon, PhD, University of Texas at Austin
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00002253
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
Clinical Trials on 1. Welcome package
-
Centre for Addiction and Mental HealthCompleted
-
Greater Manchester Mental Health NHS Foundation...University of ManchesterNot yet recruitingNo Conditions | Improving Referrals Into NHS CAMHSUnited Kingdom
-
Johns Hopkins Bloomberg School of Public HealthNational Institutes of Health (NIH)Completed
-
Geisinger ClinicCompletedHealth Promotion | Wellness ProgramsUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedHuman Immunodeficiency VirusMalawi
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Kamuzu University of Health Sciences and other collaboratorsCompleted
-
Johns Hopkins Bloomberg School of Public HealthJhpiego; Gavi, The Vaccine Alliance; Direct Consulting and LogisticsCompletedHuman Papillomavirus (HPV) Infections | Adolescent Health Services | Human Papillomavirus (HPV) Vaccines | Human Papillomavirus (HPV) VaccineNigeria
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); The George Institute; University...RecruitingDietary Sources of Sodium | Population Sodium IntakeNigeria
-
University of BotswanaCompletedHIV Infections | HypertensionBotswana
-
RANDCompletedSmoking, CigaretteUnited States